Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-06

Clinical Trial Update: Argipressin's Influence on Blood Loss During Hepatic Resection [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Argipressin's effect on intraoperative blood loss during hepatic resection in colorectal cancer with liver metastases. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Argipressin (vasopressin)

Snippet

Sponsor: Kristina Svennerholm | Conditions: Colon Cancer Liver Metastasis, Inflammatory Response | Phase 4 | Status: COMPLETED